LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.36 | 27.76 | 606 | 320 | 1.8916 | 1.3960 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 5.36 | 27.76 | 884 | 320 | 2.7594 | 1.6666 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.06 | 27.76 | 691 | 360 | 1.9194 | 1.3858 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 7.06 | 27.76 | 951 | 360 | 2.6417 | 1.6010 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.76 | 27.76 | 762 | 401 | 1.8996 | 1.3624 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.76 | 27.76 | 1 | 401 | 0.0025 | -0.5779 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 8.76 | 27.76 | 1061 | 401 | 2.6449 | 1.5743 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.46 | 27.76 | 12 | 438 | 0.0274 | -0.1899 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.46 | 27.76 | 837 | 438 | 1.9082 | 1.3523 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.46 | 27.76 | 7 | 438 | 0.0160 | -0.2925 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 10.46 | 27.76 | 1134 | 438 | 2.5852 | 1.5388 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.17 | 27.76 | 14 | 489 | 0.0286 | -0.1524 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.17 | 27.76 | 885 | 489 | 1.8096 | 1.3081 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.17 | 27.76 | 28 | 489 | 0.0573 | 0.0021 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 12.17 | 27.76 | 1237 | 489 | 2.5293 | 1.5026 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.87 | 27.76 | 162 | 604 | 0.2679 | 0.4871 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.87 | 27.76 | 940 | 604 | 1.5545 | 1.2087 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.87 | 27.76 | 341 | 604 | 0.5639 | 0.7582 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 13.87 | 27.76 | 1343 | 604 | 2.2209 | 1.3932 | MN20160318_Q01 | J07 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 15.58 | 27.76 | 260 | 685 | 0.3793 | 0.6219 | MN20160318_Q01 | E09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 15.58 | 27.76 | 983 | 685 | 1.4338 | 1.1620 | MN20160318_Q01 | E09 |